![]() | |
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C22H26ClN3O |
Molar mass | 383.92 g·mol−1 |
3D model (JSmol) | |
| |
|
4'Cl-CUMYL-PINACA (also known asSGT-157) is anindazole-3-carboxamide basedsynthetic cannabinoid compound, first disclosed in a 2014 patent.[1] It has been sold as adesigner drug, first reported in 2020 alongside two similar compounds 4'F-CUMYL-5F-PICA (SGT-64) and 4'F-CUMYL-5F-PINACA (SGT-65),[2] and the metabolism of these compounds has been studied to assist with their identification in forensic casework.[3]
![]() | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |